Both patients, aged 72 and 73 years, with JAK2-negative suspected PV, had typical features of myeloproliferative disorders, including splenomegaly, and required repeated phlebotomy and hydroxyurea therapy. This evidence concerns the gene JAK2 and acquired polycythemia vera.